ARTICLE | Clinical News
Xadago safinamide regulatory update
December 22, 2014 8:00 AM UTC
EMA’s CHMP recommended approval of Xadago safinamide from Zambon to treat patients with idiopathic Parkinson’s disease. Xadago is under review as add-on therapy to a stable dose of levodopa alone or i...